Data / Form D filings / Zurex Pharma, Inc.
Zurex Pharma, Inc.: Form D filings
Zurex Pharma, Inc., a pharmaceuticals company in Middleton, WI, filed 6 Form D notices with the SEC between 2012 and 2023. The latest, on December 29, 2023, reports $3.8 million sold of a $4 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2113 EAGLE DRIVE, Middleton, WI, 53562
- Phone
- (608) 203-9090
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1551289
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | New notice | $4,000,000 | $3,779,232 | $220,768 | 14 | Dec 14, 2023 | sec.gov |
| Jun 16, 2020 | New notice | $15,000,000 | $7,495,040 | $7,504,960 | 18 | Jun 4, 2020 | sec.gov |
| Jun 11, 2018 | New notice | $2,999,997 | $2,237,490 | $762,507 | 11 | May 25, 2018 | sec.gov |
| Aug 11, 2016 | New notice | $8,000,000 | $6,236,068 | $1,763,932 | 26 | Aug 2, 2016 | sec.gov |
| Jul 1, 2014 | New notice | $5,118,586 | $4,127,158 | $991,428 | 13 | Jun 23, 2014 | sec.gov |
| Jun 7, 2012 | New notice | $6,200,000 | $6,200,000 | 11 | May 17, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander M Kasper | Executive Officer, Director | |
| Frederick A. Robertson | Director |
Every Form D from the week of Dec 25, 2023 · All recent filings in Wisconsin · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zurex Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.